نتائج البحث

1

Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement

المؤلفون: Jacopo Nanni, Cristina Papayannidis, Antonio Curti, Francesco Barbato, Stefania Paolini, Sarah Parisi, Michele Cavo, Francesca Bonifazi, Mario Arpinati, Gianluca Cristiano, Giovanni Marconi, Chiara Sartor

المساهمون: Cristiano G., Nanni J., Sartor C., Parisi S., Marconi G., Barbato F., Arpinati M., Bonifazi F., Curti A., Cavo M., Paolini S., Papayannidis C.

المصدر: Acta Haematologica. 144:688-692

مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, medicine.medical_treatment, Fusion Proteins, bcr-abl, Protein Kinase Inhibitor, Chromosomal translocation, Hematopoietic stem cell transplantation, Philadelphia chromosome, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, chemistry.chemical_compound, Bone Marrow, Positron Emission Tomography Computed Tomography, hemic and lymphatic diseases, Internal medicine, Medicine, Imidazole, Chemotherapy, Acute leukemia, business.industry, Ponatinib, Myeloid leukemia, Hematology, General Medicine, Middle Aged, medicine.disease, Treatment Outcome, chemistry, Nelarabine, Pyridazine, business, T-cell acute lymphoblastic leukemia, Human, medicine.drug

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9817e9a4d94ebcf35ffc08bcc79cc94eTest
https://doi.org/10.1159/000516003Test

2

INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia

المساهمون: Martinelli, Giovanni, Papayannidis, Cristina, Piciocchi, Alfonso, Robustelli, Valentina, Soverini, Simona, Terragna, Carolina, Marconi, Giovanni, Lemoli, Roberto Massimo, Guolo, Fabio, Fornaro, Antonella, Lunghi, Monia, de Fabritiis, Paolo, Candoni, Anna, Selleri, Carmine, Simonetti, Federico, Bocchia, Monica, Vitale, Antonella, Frison, Luca, Tedeschi, Alessandra, Cuneo, Antonio, Bonifacio, Massimiliano, Martelli, Maria Paola, D'Ardia, Stefano, Trappolini, Silvia, Tosi, Patrizia, Galieni, Piero, Fabbiano, Francesco, Abbenante, Maria Chiara, Granier, Muriel, Zhu, Zhaoyin, Wang, Mingyue, Sartor, Chiara, Paolini, Stefania, Cavo, Michele, Foà, Robin, Fazi, Paola, Vignetti, Marco, Baccarani, Michele

مصطلحات موضوعية: medicine.medical_specialty, Population, Gastroenterology, Disease-Free Survival, chemistry.chemical_compound, Prednisone, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Tyrosine kinase inhibitors, Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL), GIMEMA LAL 1811, medicine, Clinical endpoint, Humans, Philadelphia Chromosome, Prospective Studies, education, Adverse effect, Aged, education.field_of_study, biology, business.industry, Ponatinib, Imidazoles, Hematology, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Settore MED/15, Rash, Pyridazines, Transplantation, chemistry, Alanine transaminase, biology.protein, medicine.symptom, business, medicine.drug

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::532a7ef6c6f327838c21185db5ce9234Test
http://hdl.handle.net/11567/1078678Test

3

Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial

المساهمون: Gay F., Musto P., Rota-Scalabrini D., Bertamini L., Belotti A., Galli M., Offidani M., Zamagni E., Ledda A., Grasso M., Ballanti S., Spadano A., Cea M., Patriarca F., D'Agostino M., Capra A., Giuliani N., de Fabritiis P., Aquino S., Palmas A., Gamberi B., Zambello R., Petrucci M.T., Corradini P., Cavo M., Boccadoro M.

مصطلحات موضوعية: Male, Antibodies, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Bortezomib, Combined Modality Therapy, Cyclophosphamide, Dexamethasone, Female, Follow-Up Studies, Hematopoietic Stem Cell Transplantation, Humans, Lenalidomide, Melphalan, Middle Aged, Multiple Myeloma, Oligopeptides, Prognosis, Survival Rate, Thalidomide, Transplantation, Autologous, chemistry.chemical_compound, Maintenance therapy, Monoclonal, Medicine, multiple myeloma, newly diagnosed, carfilzomib, cyclophosphamide, lenalidomide, dexamethasone, induction treatment, autologous stem-cell transplantation, maintenance treatment, phase 2, trial, Multiple myeloma, carfilzomib, trial, induction treatment, Oncology, Oligopeptide, newly diagnosed, Autologous, Human, medicine.drug, medicine.medical_specialty, Prognosi, autologous stem-cell transplantation, Antibodies, Follow-Up Studie, Internal medicine, Autologous transplantation, Transplantation, Antineoplastic Combined Chemotherapy Protocol, maintenance treatment, business.industry, medicine.disease, Settore MED/15, Carfilzomib, chemistry, phase 2, business

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4ee9f82acbff156d6f0b7336cbb430aTest
https://hdl.handle.net/2108/318985Test

4

Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia

المساهمون: Bruno S., Bandini L., Patuelli A., Robustelli V., Venturi C., Mancini M., Forte D., De Santis S., Monaldi C., Grassi A., Chiurumbolo G., Paolini S., Cristiano G., Papayannidis C., Sartor C., Nanni J., Ottaviani E., Curti A., Cavo M., Soverini S.

المصدر: Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e21852780345e8d699e776a253f17c8Test
http://europepmc.org/articles/PMC8514815Test

5

Real-world use of thrombopoietin receptor agonists in elderly patients with primary immune thrombocytopenia

المساهمون: Palandri, F, Rossi, E, Bartoletti, D, Ferretti, A, Ruggeri, M, Lucchini, E, Carrai, V, Barcellini, W, Patriarca, A, Rivolti, E, Consoli, U, Cantoni, S, Oliva, En, Chiurazzi, F, Caocci, G, Giuffrida, G, Borchiellini, A, Auteri, G, Baldacci, E, Carli, G, Nicolosi, D, Sutto, E, Carpenedo, M, Cavo, M, Mazzucconi, Mg, Zaja, F, De Stefano, V, Rodeghiero, F, Vianelli, N., Palandri F., Rossi E., Bartoletti D., Ferretti A., Ruggeri M., Lucchini E., Carrai V., Barcellini W., Patriarca A., Rivolti E., Consoli U., Cantoni S., Oliva E.N., Chiurazzi F., Caocci G., Giuffrida G., Borchiellini A., Auteri G., Baldacci E., Carli G., Nicolosi D., Sutto E., Carpenedo M., Cavo M., Mazzucconi M.G., Zaja F., De Stefano V., Rodeghiero F., Vianelli N.

مصطلحات موضوعية: Male, Receptors, Fc, Biochemistry, Gastroenterology, Benzoates, chemistry.chemical_compound, Older patients, Romiplostim, Retrospective Studie, Hydrazine, Medicine, Platelet, Aged, 80 and over, Hematology, Middle Aged, Thrombosis, Hydrazines, Thrombopoietin, Idiopathic Thrombocytopenic Purpura, Eltrombopag, Female, Receptors, Thrombopoietin, medicine.drug, Human, Thrombopoietin Receptor Agonists, medicine.medical_specialty, Immune Thrombocytopenia, Recombinant Fusion Proteins, Immunology, Hemorrhage, Follow-Up Studie, Benzoate, Internal medicine, Humans, Retrospective Studies, Aged, Purpura, Thrombocytopenic, Idiopathic, business.industry, Cell Biology, medicine.disease, Immune thrombocytopenia, Settore MED/15 - MALATTIE DEL SANGUE, chemistry, Pyrazole, Pyrazoles, business, Fibrinolytic agent, Follow-Up Studies, Recombinant Fusion Protein

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84dfa4013b2d76cb869451f0229a562bTest
https://ashpublications.org/blood/article-abstract/138/7/571/475829Test/

6

Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in elderly patients with relapsed multiple myeloma: IKEMA subgroup analysis

المؤلفون: Michele Cavo, Gabor Mikala, Andrew Lim, Münci Yağcı, Ivan Spicka, Laura Rosiñol, Sandrine Schwab, Kwee Yong, Youngil Koh, Gaëlle Asset, Thierry Facon, Albert Oriol, Thomas G. Martin, Marie-Laure Risse, Gracia Martinez, Philippe Moreau

المصدر: Hematological Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Clinical Lymphoma Myeloma & Leukemia
Journal of Clinical Oncology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e04660ff8bc273595161600f5c6de8d9Test
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7118Test

7

Isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma patients with high-risk cytogenetics : IKEMA subgroup analysis

المؤلفون: Spicka, Ivan, Moreau, Philippe, Martin, Thomas G., Facon, Thierry, Martínez, Gracia, Oriol, Albert, Koh, Youngil, Lim, Andrew, Mikala, Gabor, Rosiñol, Laura, Yağci, Münci, Cavo, Michele, Risse, Marie-Laure, Asset, Gaëlle, Macé, Sandrine, Van de Velde, Helgi, Yong, Kwee, Universitat Autònoma de Barcelona

المصدر: Clinical Lymphoma Myeloma & Leukemia
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
European Journal of Haematology
Journal of Clinical Oncology

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dec428cde713255afa6220ad1dd8781Test
https://ddd.uab.cat/record/270517Test

8

Once-weekly versus twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: a pooled analysis of two phase I/II studies

المؤلفون: Maria Teresa Petrucci, Mario Boccadoro, Roberto Mina, Massimo Offidani, Pellegrino Musto, Vittorio Montefusco, Stefano Spada, Elena Ponticelli, Giulia Benevolo, Piero Galieni, Antonio Palumbo, Gianluca Gaidano, Michele Cavo, Sara Bringhen, Tommaso Caravita di Toritto, Francesco Di Raimondo, Stelvio Ballanti, Alessandra Larocca

المساهمون: Bringhen, Sara, Mina, Roberto, Petrucci, Maria Teresa, Gaidano, Gianluca, Ballanti, Stelvio, Musto, Pellegrino, Offidani, Massimo, Spada, Stefano, Benevolo, Giulia, Ponticelli, Elena, Galieni, Piero, Cavo, Michele, Di Toritto, Tommaso Caravita, Di Raimondo, Francesco, Montefusco, Vittorio, Palumbo, Antonio, Boccadoro, Mario, Larocca, Alessandra

المصدر: Haematologica

مصطلحات موضوعية: Male, medicine.medical_specialty, Cyclophosphamide, Antineoplastic Agents, carfilzomib,multiple myeloma, Gastroenterology, Article, Plasma Cell Disorders, Drug Administration Schedule, Maintenance Chemotherapy, chemistry.chemical_compound, Maintenance therapy, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Medicine, Humans, Adverse effect, Survival analysis, Multiple myeloma, Dexamethasone, Aged, Aged, 80 and over, business.industry, Induction chemotherapy, Hematology, Induction Chemotherapy, Middle Aged, medicine.disease, Prognosis, Carfilzomib, Survival Analysis, Treatment Outcome, chemistry, Female, business, Multiple Myeloma, Oligopeptides, medicine.drug

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2dd9a4a3d07df79b7db53cf590f8481Test
http://europepmc.org/articles/PMC6669142Test

9

Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia

المساهمون: Ghelli Luserna Di Rorà, Andrea, Beeharry, Neil, Imbrogno, Enrica, Ferrari, Anna, Robustelli, Valentina, Righi, Simona, Sabattini, Elena, Verga Falzacappa, Maria Vittoria, Ronchini, Chiara, Testoni, Nicoletta, Baldazzi, Carmen, Papayannidis, Cristina, Abbenante, Maria Chiara, Marconi, Giovanni, Paolini, Stefania, Parisi, Sarah, Sartor, Chiara, Fontana, Maria Chiara, De Matteis, Serena, Iacobucci, Ilaria, Pelicci, Pier Giuseppe, Cavo, Michele, Yen, Timothy J, Martinelli, Giovanni

المصدر: Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-18 (2018)
Journal of Hematology & Oncology

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.medical_specialty, T cell, Cell Cycle Proteins, Acute lymphoblastic leukemia, Peripheral blood mononuclear cell, lcsh:RC254-282, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Cell Line, Tumor, Internal medicine, medicine, Humans, Clofarabine, Molecular Biology, G2/M checkpoint, Hematology, business.industry, lcsh:RC633-647.5, Research, Ponatinib, Nuclear Proteins, lcsh:Diseases of the blood and blood-forming organs, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Protein-Tyrosine Kinases, Chemo-sensitizer agent, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 3. Good health, 030104 developmental biology, medicine.anatomical_structure, Oncology, chemistry, 030220 oncology & carcinogenesis, Cancer cell, Cancer research, WEE1 inhibitor, business, Bosutinib, Tyrosine kinase, medicine.drug

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cde554c9336091ea0128cf0f551924e5Test
http://link.springer.com/article/10.1186/s13045-018-0641-1Test

10

Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

المساهمون: Richardson P.G., Kumar S.K., Masszi T., Grzasko N., Bahlis N.J., Hansson M., Pour L., Sandhu I., Ganly P., Baker B.W., Jackson S.R., Stoppa A.-M., Gimsing P., Garderet L., Touzeau C., Buadi F.K., Laubach J.P., Cavo M., Darif M., Labotka R., Berg D., Moreau P.

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffe0355620e6432638e8710918413772Test
http://hdl.handle.net/11585/865187Test

تنقيح النتائج